These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37195412)

  • 1. Dysregulation of genes coding for proteins involved in metabolic processes in mucopolysaccharidoses, evidenced by a transcriptomic approach.
    Pierzynowska K; Deresz P; Węgrzyn G; Gaffke L
    Metab Brain Dis; 2023 Aug; 38(6):2133-2144. PubMed ID: 37195412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of genes involved in apoptosis is dysregulated in mucopolysaccharidoses as revealed by pilot transcriptomic analyses.
    Brokowska J; Pierzynowska K; Gaffke L; Rintz E; Węgrzyn G
    Cell Biol Int; 2021 Mar; 45(3):549-557. PubMed ID: 32125037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex Changes in the Efficiency of the Expression of Many Genes in Monogenic Diseases, Mucopolysaccharidoses, May Arise from Significant Disturbances in the Levels of Factors Involved in the Gene Expression Regulation Processes.
    Cyske Z; Gaffke L; Pierzynowska K; Węgrzyn G
    Genes (Basel); 2022 Mar; 13(4):. PubMed ID: 35456399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underestimated Aspect of Mucopolysaccharidosis Pathogenesis: Global Changes in Cellular Processes Revealed by Transcriptomic Studies.
    Gaffke L; Pierzynowska K; Podlacha M; Hoinkis D; Rintz E; Brokowska J; Cyske Z; Wegrzyn G
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in expressions of genes involved in the regulation of cellular processes in mucopolysaccharidoses as assessed by fibroblast culture-based transcriptomic analyses.
    Gaffke L; Pierzynowska K; Krzelowska K; Piotrowska E; Węgrzyn G
    Metab Brain Dis; 2020 Dec; 35(8):1353-1360. PubMed ID: 32886284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle disturbances in mucopolysaccharidoses: Transcriptomic and experimental studies on cellular models.
    Brokowska J; Gaffke L; Pierzynowska K; Cyske Z; Węgrzyn G
    Exp Biol Med (Maywood); 2022 Sep; 247(18):1639-1649. PubMed ID: 36000158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Expression-Related Changes in Morphologies of Organelles and Cellular Component Organization in Mucopolysaccharidoses.
    Gaffke L; Pierzynowska K; Rintz E; Cyske Z; Giecewicz I; Węgrzyn G
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic Changes Related to Cellular Processes with Particular Emphasis on Cell Activation in Lysosomal Storage Diseases from the Group of Mucopolysaccharidoses.
    Rintz E; Gaffke L; Podlacha M; Brokowska J; Cyske Z; Węgrzyn G; Pierzynowska K
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32366041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of vesicle trafficking dysregulation to the pathomechanism of mucopolysaccharidosis.
    Gaffke L; Pierzynowska K; Cyske Z; Podlacha M; Węgrzyn G
    Biochem Biophys Res Commun; 2023 Jul; 665():107-117. PubMed ID: 37149983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cellular processes occurring in mucopolysaccharidoses as underestimated pathomechanisms of these diseases.
    Gaffke L; Pierzynowska K; Podlacha M; Brokowska J; Węgrzyn G
    Cell Biol Int; 2021 Mar; 45(3):498-506. PubMed ID: 31855304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different?
    Węgrzyn G; Jakóbkiewicz-Banecka J; Narajczyk M; Wiśniewski A; Piotrowska E; Gabig-Cimińska M; Kloska A; Słomińska-Wojewódzka M; Korzon-Burakowska A; Węgrzyn A
    Med Hypotheses; 2010 Dec; 75(6):605-9. PubMed ID: 20732748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Putative biological mechanisms of efficiency of substrate reduction therapies for mucopolysaccharidoses.
    Banecka-Majkutewicz Z; Jakóbkiewicz-Banecka J; Gabig-Cimińska M; Węgrzyn A; Węgrzyn G
    Arch Immunol Ther Exp (Warsz); 2012 Dec; 60(6):461-8. PubMed ID: 22949095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired ion homeostasis as a possible associate factor in mucopolysaccharidosis pathogenesis: transcriptomic, cellular and animal studies.
    Gaffke L; Szczudło Z; Podlacha M; Cyske Z; Rintz E; Mantej J; Krzelowska K; Węgrzyn G; Pierzynowska K
    Metab Brain Dis; 2022 Feb; 37(2):299-310. PubMed ID: 34928474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Base of Behavioral Disorders in Mucopolysaccharidoses: Transcriptomic Studies.
    Pierzynowska K; Gaffke L; Podlacha M; Węgrzyn G
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Mucopolysaccharidoses, an Update.
    Fecarotta S; Tarallo A; Damiano C; Minopoli N; Parenti G
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know.
    Filocamo M; Tomanin R; Bertola F; Morrone A
    Ital J Pediatr; 2018 Nov; 44(Suppl 2):129. PubMed ID: 30442161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.
    Jakóbkiewicz-Banecka J; Piotrowska E; Narajczyk M; Barańska S; Wegrzyn G
    J Biomed Sci; 2009 Mar; 16(1):26. PubMed ID: 19272193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn screening and diagnosis of mucopolysaccharidoses.
    Tomatsu S; Fujii T; Fukushi M; Oguma T; Shimada T; Maeda M; Kida K; Shibata Y; Futatsumori H; Montaño AM; Mason RW; Yamaguchi S; Suzuki Y; Orii T
    Mol Genet Metab; 2013; 110(1-2):42-53. PubMed ID: 23860310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses.
    Piotrowska E; Jakóbkiewicz-Banecka J; Barańska S; Tylki-Szymańska A; Czartoryska B; Wegrzyn A; Wegrzyn G
    Eur J Hum Genet; 2006 Jul; 14(7):846-52. PubMed ID: 16670689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causes of death in mucopolysaccharidoses.
    Rintz E; Banacki M; Ziemian M; Kobus B; Wegrzyn G
    Mol Genet Metab; 2024 Jul; 142(3):108507. PubMed ID: 38815294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.